Skip to main content
Funded Studies

Helen Mitchell, PhD

Director, Discovery Chemistry at Merck & Co., Inc.

Location: West Point, PA United States

Dr. Helen Mitchell obtained her PhD from the University of California, San Diego, where she completed the total synthesis of a powerful antibiotic called Everninomicin 13,384-1. Dr. Mitchell continued in the field of organic synthesis during her postdoctoral fellowship at the Scripps Research Institute, where she worked on the total synthesis of other natural products. She joined Merck Research Labs at West Point in July of 2001 and worked on several nuclear receptor programs for the treatment of osteoporosis, cancer and inflammatory diseases. She subsequently worked on several programs to target pain and contributed to two drugs for the treatment of migraine. She has held various roles including management of CRO resources and expansion of parallel methods and data analysis.  Currently, Dr. Mitchell is director of the Technology Enabled Chemistry Group and manages the parallel medicinal chemistry and high-throughput purification groups at West Point.

Associated Grants

  • Discovery of PET Tracers for Measuring Alpha-synuclein


  • (SUPPLEMENT) Development of an Imaging Tracer for Measuring Alpha-synuclein


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.